TY - JOUR
KW - Adult
KW - Baltimore
KW - Female
KW - Humans
KW - Methadone/therapeutic use
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/therapy
KW - Patient Dropouts/statistics & numerical data
KW - Pregnancy
KW - Pregnancy Complications/therapy
KW - Retention in Care/statistics & numerical data
KW - Alcohol
KW - Drug Use
KW - Mental Health
AU - B. Jancaitis
AU - S. Kelpin
AU - S. Masho
AU - J. May
AU - N. A. Haug
AU - D. Svikis
A1 - 
AB - Opioid use during pregnancy is rising, with an estimated 14-22% of women obtaining an opioid prescription during pregnancy. Methadone maintenance therapy (MMT) has been the gold standard for treatment of opioid use disorders during pregnancy; however, its use is limited in clinical practice due to availability, stigma, and reluctance on the part of clinicians. The present study compared against medical advice (AMA) treatment dropout from seven days of residential care between pregnant women diagnosed with opioid dependence who elected either MMT (n = 119) or non-pharmacological treatment (NPT) (n = 91) within the same treatment program in Baltimore, Maryland from 1996 to 1998. Multiple logistic regression analysis was conducted to compare the rate of AMA drop out between the two modalities. Patients who elected NPT were 2.77 times as likely to leave residential treatment as patients who elected MMT (adjusted odds ratio [OR = 2.77, 95% confidence interval [CI]: 1.23-6.17]. AMA was associated with interviewer-assessed drug severity and patient's rating of the importance of psychiatric treatment. The present findings further support the clinical utility of MMT and suggest that policies that facilitate the implementation of MMT in clinical practice would be beneficial to the engagement and retention of pregnant women with opioid use disorders.
AD - Department of Family Medicine and Population Health, Division of Epidemiology, Virginia Commonwealth University, Richmond, VA, USA.; Richmond Behavioral Health Authority, Richmond, VA, USA.; Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.; Department of Family Medicine and Population Health, Division of Epidemiology, Virginia Commonwealth University, Richmond, VA, USA.; Institute for Women's Health, Virginia Commonwealth University, Richmond, VA, USA.; Richmond Behavioral Health Authority, Richmond, VA, USA.; Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.; Department of Psychology, Palo Alto University, Palo Alto, CA, USA.; Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.; Institute for Women's Health, Virginia Commonwealth University, Richmond, VA, USA.
BT - Women & health
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 1
DO - 10.1080/03630242.2019.1610829
IS - 1
JF - Women & health
LA - eng
M1 - Journal Article
N2 - Opioid use during pregnancy is rising, with an estimated 14-22% of women obtaining an opioid prescription during pregnancy. Methadone maintenance therapy (MMT) has been the gold standard for treatment of opioid use disorders during pregnancy; however, its use is limited in clinical practice due to availability, stigma, and reluctance on the part of clinicians. The present study compared against medical advice (AMA) treatment dropout from seven days of residential care between pregnant women diagnosed with opioid dependence who elected either MMT (n = 119) or non-pharmacological treatment (NPT) (n = 91) within the same treatment program in Baltimore, Maryland from 1996 to 1998. Multiple logistic regression analysis was conducted to compare the rate of AMA drop out between the two modalities. Patients who elected NPT were 2.77 times as likely to leave residential treatment as patients who elected MMT (adjusted odds ratio [OR = 2.77, 95% confidence interval [CI]: 1.23-6.17]. AMA was associated with interviewer-assessed drug severity and patient's rating of the importance of psychiatric treatment. The present findings further support the clinical utility of MMT and suggest that policies that facilitate the implementation of MMT in clinical practice would be beneficial to the engagement and retention of pregnant women with opioid use disorders.
PY - 2020
SN - 1541-0331; 0363-0242; 0363-0242
SP - 1
EP - 11
EP - 
T1 - Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment
T2 - Women & health
TI - Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 31068095
U3 - 10.1080/03630242.2019.1610829
VL - 60
VO - 1541-0331; 0363-0242; 0363-0242
Y1 - 2020
Y2 - Jan
ER -